Dermoscopy Aids in the Diagnosis of Discoid Lupus Erythematosus
May 16th, 2025
Herein, we present a protocol to demonstrate the utility of dermoscopy in rheumatic diseases. In addition, we described the dermoscopic manifestations of discoid lupus erythematosus skin lesions.
Our research scope is the application of dermoscopy in autoimmune diseases. We aim to figure out how dermoscopy helps in the diagnosis of discoid lupus erythematosus.
So recent developments in the field of dermoscopy include a significant improvement in the resolution of dermoscopes, the emergence of remote dermoscopy software, and AI-assisted treatment, etc.
This technique has the advantages of being non-invasive and performed in real-time and can thus assist in determining the site of skin biopsy.
[Presenter] To begin, review the patient's medical history and conduct a thorough physical examination. Identify patients with suspected discoid lupus erythematosus, particularly those presenting with erythema on the face and other exposed areas accompanied by adherent scales. Also assess for lesions in non-exposed areas. Ensure the examination room is properly set up. If natural light is insufficient, use artificial lighting that provides even illumination. Adjust the room temperature to approximately 20 to 25 degrees Celsius and ensure the space is clean, organized, and free from distractions or obstructions. Guide the patient into the examination room and have them either sit on the examination chair or lie on the examination bed. Position the chair against a black curtain or a similar background to clearly expose the skin lesions. Using a mild non-irritating cleanser, such as 75% alcohol swabs, cleanse the skin to remove oil, dirt, or cosmetics. For areas such as the scalp, shave the area using a clean, sharp razor, taking care to avoid cuts or abrasions. Ensure the skin is completely dry before proceeding further. Double click the software icon on the computer to start the dermoscopy application. Check the magnification levels typically between 20 and 40 times, and verify the quality of polarized light to ensure the overall functionality of the device. Use the high-definition camera mode of the dermoscope to capture a general photograph of the skin lesions. First, disinfect the lens of the dermatoscope with a cotton ball soaked in 75% alcohol and gently dry it. Now, gently place the dermoscope on the surface of the skin to begin the examination. Slowly adjust the focus knob until the skin lesion appears clearly visible. Switch to polarized light mode to improve the visibility of skin structures. Observe the shape of the lesion and take note of any irregularities or asymmetries. Examine the color for pigmentation variations. Inspect the vascular structure focusing on patterns and the density of blood vessels, noting the presence of thick arborising vessels commonly seen in discoid lupus erythematosus lesions. Adjust the magnification using the plus and minus buttons on the lens to capture different angles of the lesion and ensure comprehensive visualization of all relevant details. Hold the dermoscope steadily and gently alter the angle between the device and the skin. Move slowly to avoid major shifts that may disrupt observation. Continue observing the image through the dermoscope and stop adjusting once the clearest image is obtained. Record all dermoscopic features of the skin lesions and write a detailed descriptive report. Typical features in discoid lupus erythematosus include whitish or yellowish follicular keratotic plugs over erythematous background, white parafollicular halo, follicular red dots, arborising vessels, linear, irregular vessels. After completing the dermoscopic examination, review the patient's clinical symptoms, medical history, and results from related tests. If the diagnosis is definitive, advise the patient on the next steps, including lifestyle changes, topical medications, or referrals to specialists. Facial skin lesions of a male patient with DLE showed erythema on the tip of the nose with mild infiltration. A few fine scales and follicular keratotic plugs were accompanied by a white halo with surrounding erythema and associated pigmentation.
View the full transcript and gain access to thousands of scientific videos
Overview
This article presents a protocol for utilizing dermoscopy in diagnosing rheumatic diseases, specifically focusing on discoid lupus erythematosus (DLE). The study outlines the dermoscopic features associated with DLE skin lesions.
Key Study Components
Area of Science
- Dermoscopy
- Autoimmune diseases
- Rheumatology
Background
- Dermoscopy is a non-invasive technique used for skin examination.
- Recent advancements include improved resolution and AI-assisted tools.
- It aids in the diagnosis of various skin conditions, including autoimmune diseases.
- Discoid lupus erythematosus presents specific dermoscopic features.
Purpose of Study
- To demonstrate the utility of dermoscopy in diagnosing DLE.
- To identify and describe the dermoscopic manifestations of DLE lesions.
- To enhance diagnostic accuracy in rheumatic diseases.
Methods Used
- Review of patient medical history and physical examination.
- Use of dermoscopy to examine skin lesions.
- Documentation of dermoscopic features and clinical symptoms.
- Assessment of biopsy sites based on dermoscopic findings.
Main Results
- Identification of characteristic features such as keratotic plugs and vascular patterns.
- Improved visualization of skin lesions through polarized light mode.
- Detailed reports on dermoscopic findings assist in diagnosis.
- Facilitated patient management through accurate diagnosis.
Conclusions
- Dermoscopy is a valuable tool in diagnosing discoid lupus erythematosus.
- It provides real-time, non-invasive insights into skin lesions.
- Proper technique and documentation are essential for effective diagnosis.
Frequently Asked Questions
Executive Industry Relevance
Dermoscopy provides a non-invasive, real-time diagnostic tool for early identification and characterization of skin lesions in autoimmune and rheumatic diseases such as discoid lupus erythematosus (DLE). Its integration into discovery-stage workflows enhances predictive confidence in lesion assessment and supports more informed biopsy site selection. This capability enables translational continuity from clinical observation to molecular investigation, reducing diagnostic ambiguity and supporting portfolio-level decision-making in dermatological and immunological research.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables precise phenotypic characterization of skin lesions relevant to autoimmune disease models.
- Supports biological de-risking by distinguishing DLE from other dermatological manifestations.
- Facilitates hypothesis-driven selection of biopsy sites for downstream molecular analysis.
- Improves predictive confidence in early-stage target validation for skin-involved rheumatic diseases.
Screening & Assay Development
- Standardizes lesion documentation for reproducible assessment across patient cohorts.
- Provides quantitative and qualitative dermoscopic outputs for assay development.
- Enables scalable, real-time screening of lesion morphology and vascular patterns.
- Supports reliable evaluation of candidate interventions in preclinical dermatology studies.
Translational & Preclinical Research
- Aligns dermoscopic features with disease-relevant biomarkers for translational research.
- Ensures continuity from clinical phenotype to preclinical model validation.
- Reduces risk of misclassification in cross-species or cross-cohort studies.
- Supports risk-adjusted advancement of dermatological and immunological assets.
Pipeline & Workflow Integration
Dermoscopy fits at the interface of clinical observation and molecular discovery, informing both early discovery and preclinical validation stages in autoimmune and dermatological pipelines.
- Discovery Biology: Enables hypothesis testing and pathway clarification through detailed lesion analysis.
- Screening: Provides reproducible, quantitative readouts for lesion morphology and vascularity.
- Analytics: Delivers standardized imaging and descriptive reports for cross-condition comparison.
- Translational Research: Bridges clinical findings with preclinical model selection and biomarker alignment.
- Enterprise Reuse: Establishes a reusable imaging and documentation platform for diverse skin-involved disease programs.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in lesion-driven disease models.
- Operational Value: Enhances standardization, reproducibility, and scalability of skin lesion assessment.
- Strategic Value: Supports informed go/no-go decisions and capital-efficient advancement of dermatology and immunology assets.
- Portfolio Impact: Enables risk-adjusted prioritization and cross-program comparability in skin-involved disease research.
Implementation Considerations
- Requires expertise in dermoscopic imaging and interpretation of lesion features.
- Needs high-resolution dermoscopy instrumentation and compatible analytical software.
- Demands standardized protocols for cross-team reproducibility and data integration.
- May require adaptation for different anatomical sites or lesion types.
- Dependent on quality of imaging and operator training for optimal results.
